medcelerator · clinician one-pager
Injection Treatment When the Body Makes Too Many Eosinophils
Fasenra (benralizumab) for hypereosinophilic syndrome
Health Canada/FDA Approved · United States, Canada, European Union · September 3, 2026
Condition: Hypereosinophilic Syndrome
Who this is for
Health Canada and the FDA have labelled Fasenra for hypereosinophilic syndrome. Japan and Switzerland have too. The UK SmPC already carries the wording. The European Union (EU) approved it on 3 July 2026. Toronto has an open paediatric trial. Authorized is not funded.
Next clinical step
Health Canada and the US Food and Drug Administration (FDA) have approved this medicine. In Canada and the United States, ask your doctor or a specialist whether it suits you. They can write a prescription. Insurance or public drug plan coverage is not guaranteed. In the European Union, authorisation is not confirmed; see Possible routes below if any are listed.
Ways to access this treatment
United States · Prescription
US prescription (FDA-labelled)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=da6aca1a-19ed-44a4-abb7-696c7d58b784
Canada · Prescription
Canada prescription (Health Canada NOC, DIN 02473232/02496135)
https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=96262
European Union · Prescription
EU prescription (European Commission decision 3 Jul 2026, HES)
https://ec.europa.eu/health/documents/community-register/html/h1252.htm
General resources for further research
Canadian Clinical Trial Search Portal (Health Canada)
Health Canada's public search of the drug and biologic clinical trials it has authorised in Canada (phase 1 to 3, since April 2013). Search by condition, drug, or trial status and see where trials are running. It replaced the Health Canada Clinical Trials Database in July 2026. A listing is not enrolment, and Health Canada does not recruit patients: ask your clinician and contact the trial sponsor.
https://clinical-trials-search.canada.ca/en/home
ClinicalTrials.gov
US National Library of Medicine registry of clinical studies. Search by condition, drug, NCT number, and location. A listing is not enrolment, eligibility, or funding. Talk with the trial contact and a clinician before assuming a slot exists.
https://clinicaltrials.gov/
CTIS (EU Clinical Trials Information System)
European Union public portal for clinical trials submitted under the Clinical Trials Regulation. Search by medicine, condition, and member state. A CTIS record is not an EMA marketing authorisation and is not enrolment.
https://euclinicaltrials.eu/
AI-produced discussion aid; not prescribing instructions. Approval does not establish coverage. Full article: https://medcelerator.com/articles/fasenra-benralizumab-hypereosinophilic-syndrome